Perinatal Outcomes Among Patients With Sepsis During Pregnancy by Blauvelt, Christine A, Nguyen, Kiana C, Cassidy, Arianna G, Gaw, Stephanie L

Get full text

845 Placental findings and adverse pregnancy outcomes in antepartum sepsis by Nguyen, Kiana C., Blauvelt, Christine A., Gaw, Stephanie L.

Get full text

1117 Do severity scoring systems for sepsis predict obstetric and neonatal outcomes? by Blauvelt, Christine A., Nguyen, Kiana C., Gaw, Stephanie L.

Get full text

Evidence-based care bundle to reduce cesarean delivery wound complications by Blauvelt, Christine A., Robles, Diana C., Cassidy, Arianna G., Duck, Meghan, Manke, Nina, Rosenstein, Melissa G.

Get full text

1087 Risk of adverse perinatal outcomes after recovery from antepartum sepsis by Blauvelt, Christine A., Nguyen, Kiana C., Cassidy, Arianna G., Gaw, Stephanie L.

Get full text

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, doubl... by Papp, K., Gottlieb, A., Reich, K., Maari, C., Gordon, K.B., Lima, R.G., Elmaraghy, H., Gallo, G., Renda, L., Park, S.Y., Burge, R., Bagel, J., Vender, Ronald, Hong, Chih‐Ho, Langley, Richard L., Albrecht, Lorne, Guenther, Lyn, Papp, Kim, Singh Ohson, Kamal K., Barber, Kirk, Lynde, Charles, Gupta, Aditya, Rosoph, Leslie, Gauthier, Jean‐Sébastien, Gooderham, Melinda, Wasel, Norman, Wiseman, Marni, Greenstein, David, Jarell, Abel, Moon, Charles, Bukhalo, Michael, Moore, Angela, Hamilton, Tiffani K., Gewirtzman, Aron, Hazan, Lydie, Crowley, Jeffrey, Teller, Craig, Smith, Stacy R., Christine Lee, M., Lee, Patricia, Dhawan, Sunil, Leonardi, Craig, Jesus, Amarilis Perez‐De, McFalda, Wendy, Fretzin, Scott, Schlesinger, Todd, Gottlieb, Scott, Jenkin, Peter, Gharib, Rola, Davis, Steven, Draelos, Zoe Diana, Godwin, Lloyd, Landis, Megan, Sanchez‐Rivera, Samuel, Fivenson, David, Kerdel, Francisco, Forman, Seth B., Gonzalez‐Chavez, Jose, Boyce, Brent, Stein‐Gold, Linda, Hudson, Charles, Brown, Constance, Coggi, James, Feser, Christina, McCune, Mark, Madkan, Vandana, Shipp, Dana Maxwell, Soto‐Raices, Oscar, Cather, Jennifer, Miller, Scott, Scott, John, Young, Douglas, Yokum, Kelley, McCracken, Gary, McElgunn, Patrick, Herrmann, James, Appel, James, Barranco, Elizabeth, Cauthen, Ashley, Sadick, Neil, De La Torre, Eneida, Taylor, Kelly, Harris, Holly Hake, Soung, Jennifer, Dimitropoulos, Vassilios, Miller, Stephen, Barnes, Cathy, Jumean‐Haddad, Rawan, Guenthner, Scott, Laquer, Vivian, Jacobs, Shahram, Nahm, Walter, Korman, Neil, Elewski, Boni, Ferris, Laura, Duffin, Kristina Callis, Pariser, David, Johnson, Brian, Travers, Jeffrey, Fried, Richard

Get full text

53907 Amlitelimab improves extent and severity of disease in adults with moderate-to-severe atopic dermatitis (AD): 24-week results from a Phase 2b trial (STREAM-AD) by Weidinger, Stephen, Igawa, Ken, Zikos, Efstathios, Weber, Christine, Wong, Wanling, Gray, Cori, Blauvelt, Andrew

Get full text

53997 Improvements on patient-reported outcome (PRO) measures with 24 weeks of amlitelimab treatment in adults with moderate-to-severe atopic dermatitis: results from a Phase 2b tr... by Blauvelt, Andrew, Zikos, Efstathios, Weber, Christine, Wong, Wanling, Gray, Cori, Weidinger, Stephan

Get full text

698 - Impact of amlitelimab (an anti-OX40 ligand antibody) on clinical outcome assessments for atopic dermatitis: results from the 52-week STREAM-AD phase 2b study in adults with m... by Blauvelt, Andrew, Chovatiya, Raj, Merola, Joseph F, Weidinger, Stephan, Igawa, Ken, Zikos, Efstathios, Weber, Christine, Wang, Jennifer, Gray, Cori

Get full text

661 - Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD) by Weidinger, Stephan, Blauvelt, Andrew, Papp, Kim, Reich, Adam, Lee, Chih-Hung, Worm, Margitta, Lynde, Charles, Kataoka, Yoko, Foley, Peter, Weber, Christine, Solente, Anne-Catherine, Adelman, Samuel, Davey, Sonya, Wong, Wanling, Rynkiewicz, Natalie, Yen, Karl, O’Malley, John T, Bernigaud, Charlotte

Get full text

523 - Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD) by Weidinger, Stephan, Blauvelt, Andrew, Papp, Kim, Reich, Adam, Lee, Chih-Hung, Worm, Margitta, Lynde, Charles, Kataoka, Yoko, Foley, Peter, Weber, Christine, Wong, Wanling, Hurbin, Fabrice, Rynkiewicz, Natalie, Yen, Karl, Wei, Xiaodan, O’Malley, John T, Bernigaud, Charlotte

Get full text

Effectiveness of antepartum intravenous iron sucrose: dose timing and impact on outcomes by Hamm, Rebecca F., Blauvelt, Christine, Wang, Eileen Y., Srinivas, Sindhu K.

Get full text

795: Timing of intravenous iron sucrose affects pre-delivery hemoglobin levels by Blauvelt, Christine, Hamm, Rebecca F., Wang, Eileen Y., Srinivas, Sindhu K.

Get full text

Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GE... by LeNoue-Newton, Michele L, Chen, Sheau-Chiann, Stricker, Thomas, Hyman, David M, Blauvelt, Natalie, Bedard, Philippe L, Meric-Bernstam, Funda, Punglia, Rinaa S, Schrag, Deborah, Lepisto, Eva M, Andre, Fabrice, Smyth, Lillian, Dogan, Semih, Yu, Celeste, Wathoo, Chetna, Levy, Mia, Eli, Lisa D, Xu, Feng, Mann, Grace, Lalani, Alshad S, Ye, Fei, Micheel, Christine M, Arnedos, Monica

Get full text

Characteristics and Outcome of AKT1 E17K -Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry by Smyth, Lillian M, Zhou, Qin, Nguyen, Bastien, Yu, Celeste, Lepisto, Eva M, Arnedos, Monica, Hasset, Michael J, Lenoue-Newton, Michele L, Blauvelt, Natalie, Dogan, Semih, Micheel, Christine M, Wathoo, Chetna, Horlings, Hugo, Hudecek, Jan, Gross, Benjamin E, Kundra, Ritika, Sweeney, Shawn M, Gao, JianJiong, Schultz, Nikolaus, Zarski, Andrew, Gardos, Stuart M, Lee, Jocelyn, Sheffler-Collins, Seth, Park, Ben H, Sawyers, Charles L, André, Fabrice, Levy, Mia, Meric-Bernstam, Funda, Bedard, Philippe L, Iasonos, Alexia, Schrag, Deborah, Hyman, David M

Get full text

Molecular Analysis of Pancreas FNA Cytocentrifugation Supernatant Fluid Is a Useful Adjunct for Cytology Evaluation for Cancer by Finkelstein, Sydney D., Solomides, Charalambos, Ellsworth, Eric, Palma, John F., Christine, Spence, Megan, Blauvelt, Bibbo, Marluce

Get full text

Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry by Siegfried, Elaine C., Jaworski, Jennifer C., Eichenfield, Lawrence F., Paller, Amy, Hebert, Adelaide A., Simpson, Eric L., Altman, Emily, Arena, Charles, Blauvelt, Andrew, Block, Julie, Boguniewicz, Mark, Chen, Suephy, Cordoro, Kelly, Hanna, Diane, Horii, Kimberly, Hultsch, Thomas, Lee, James, Leung, Donald Y., Lio, Peter, Milner, Joshua, Omachi, Theodore, Schneider, Christine, Schneider, Lynda, Sidbury, Robert, Smith, Timothy, Sugarman, Jeffrey, Taha, Sharif, Tofte, Susan, Tollefson, Megha, Tom, Wynnis L., West, Dennis P., Whitney, Lucinda, Zane, Lee

Get full text